|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
At the board meeting of Company held on 11 March 2025, Regarding the "public disclosure of forward-looking statements" as per the "Communiqué on Material Events Disclosure" (II-15.1) of Capital Markets, it has been decided to publish the Company's operational and financial expectations for 2025 as follows;
2025 Guidance (Excl. TAS 29 inflation accounting) Net Sales Growth (compared to 2024): 40% (+/- 2,5%)
EBITDA Margin (inc. IFRS 16): 4,5% (+/- 0,5%)
CAPEX: 2,5% (+/- 0,5%) of Sales
2025 Guidance (Incl. TAS 29 inflation accounting) Net Sales Growth (compared to 2024): 6% (+/- 2,0%)
EBITDA Margin (inc. IFRS 16): 2,0% (+/- 0,5%)
CAPEX: 2,5% (+/- 0,5%) of Sales
|
||||||||